Terms: = Germ cell tumor AND LMO1, RBTN1, 4004, ENSG00000166407, P25800, RHOM1, TTG1
26 results:
1. Genetic predisposition to neuroblastoma results from a regulatory polymorphism that promotes the adrenergic cell state.
Weichert-Leahey N; Shi H; Tao T; Oldridge DA; Durbin AD; Abraham BJ; Zimmerman MW; Zhu S; Wood AC; Reyon D; Joung JK; Young RA; Diskin SJ; Maris JM; Look AT
J Clin Invest; 2023 May; 133(10):. PubMed ID: 37183825
[TBL] [Abstract] [Full Text] [Related]
2. Back to the future: evolutionary biology reveals a key regulatory switch in neuroblastoma pathogenesis.
Wertman JN; Berman JN
J Clin Invest; 2023 May; 133(10):. PubMed ID: 37183823
[TBL] [Abstract] [Full Text] [Related]
3. Characteristics and survival of primary vaginal malignancy: an analysis of the german nationwide cancer registry data.
Forner DM
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1115-1122. PubMed ID: 35314872
[TBL] [Abstract] [Full Text] [Related]
4. Genetic predisposition and chromosome instability in neuroblastoma.
Tonini GP; Capasso M
Cancer Metastasis Rev; 2020 Mar; 39(1):275-285. PubMed ID: 31927719
[TBL] [Abstract] [Full Text] [Related]
5. lmo1 polymorphisms and the risk of neuroblastoma: Assessment of meta-analysis of case-control studies.
Hashemi M; Sarabandi S; Karami S; Śmieja J; Moazeni-Roodi A; Ghavami S; Łos MJ
J Cell Mol Med; 2020 Jan; 24(2):1160-1168. PubMed ID: 31830377
[TBL] [Abstract] [Full Text] [Related]
6. ASCL1 is a MYCN- and lmo1-dependent member of the adrenergic neuroblastoma core regulatory circuitry.
Wang L; Tan TK; Durbin AD; Zimmerman MW; Abraham BJ; Tan SH; Ngoc PCT; Weichert-Leahey N; Akahane K; Lawton LN; Rokita JL; Maris JM; Young RA; Look AT; Sanda T
Nat Commun; 2019 Dec; 10(1):5622. PubMed ID: 31819055
[TBL] [Abstract] [Full Text] [Related]
7. Detection of novel fusion-transcripts by RNA-Seq in T-cell lymphoblastic lymphoma.
López-Nieva P; Fernández-Navarro P; Graña-Castro O; Andrés-León E; Santos J; Villa-Morales M; Cobos-Fernández MÁ; González-Sánchez L; Malumbres M; Salazar-Roa M; Fernández-Piqueras J
Sci Rep; 2019 Mar; 9(1):5179. PubMed ID: 30914738
[TBL] [Abstract] [Full Text] [Related]
8. Collaborative ISL1/GATA3 interaction in controlling neuroblastoma oncogenic pathways overlapping with but distinct from MYCN.
Zhang Q; Zhang Q; Jiang X; Ye Y; Liao H; Zhu F; Yan J; Luo L; Tian L; Jiang C; Chen Y; Liang X; Sun Y
Theranostics; 2019; 9(4):986-1000. PubMed ID: 30867811
[No Abstract] [Full Text] [Related]
9. FGF represses metastasis of neuroblastoma regulated by MYCN and TGF-β1 induced lmo1 via control of let-7 expression.
Wang XH; Wu HY; Gao J; Wang XH; Gao TH; Zhang SF
Brain Res; 2019 Feb; 1704():219-228. PubMed ID: 30321496
[TBL] [Abstract] [Full Text] [Related]
10. Indirect Down-regulation of tumor-suppressive
Saeki N; Saito A; Sugaya Y; Amemiya M; Sasaki H
Cancer Genomics Proteomics; 2018; 15(5):413-420. PubMed ID: 30194082
[TBL] [Abstract] [Full Text] [Related]
11. Chromatin Immunoprecipitation and DNA Sequencing Identified a LIMS1/ILK Pathway Regulated by lmo1 in Neuroblastoma.
Saeki N; Saito A; Sugaya Y; Amemiya M; Ono H; Komatsuzaki R; Yanagihara K; Sasaki H
Cancer Genomics Proteomics; 2018; 15(3):165-174. PubMed ID: 29695398
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
Hungate EA; Applebaum MA; Skol AD; Vaksman Z; Diamond M; McDaniel L; Volchenboum SL; Stranger BE; Maris JM; Diskin SJ; Onel K; Cohn SL
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117357
[TBL] [Abstract] [Full Text] [Related]
13. When lmo1 Meets MYCN, Neuroblastoma Is Metastatic.
Liu Z; Thiele CJ
Cancer Cell; 2017 Sep; 32(3):273-275. PubMed ID: 28898690
[TBL] [Abstract] [Full Text] [Related]
14. lmo1 Synergizes with MYCN to Promote Neuroblastoma Initiation and Metastasis.
Zhu S; Zhang X; Weichert-Leahey N; Dong Z; Zhang C; Lopez G; Tao T; He S; Wood AC; Oldridge D; Ung CY; van Ree JH; Khan A; Salazar BM; Lummertz da Rocha E; Zimmerman MW; Guo F; Cao H; Hou X; Weroha SJ; Perez-Atayde AR; Neuberg DS; Meves A; McNiven MA; van Deursen JM; Li H; Maris JM; Look AT
Cancer Cell; 2017 Sep; 32(3):310-323.e5. PubMed ID: 28867147
[TBL] [Abstract] [Full Text] [Related]
15. lmo1 gene polymorphisms contribute to decreased neuroblastoma susceptibility in a Southern Chinese population.
He J; Zhong W; Zeng J; Zhu J; Zhang R; Wang F; Yang T; Zou Y; Xia H
Oncotarget; 2016 Apr; 7(16):22770-8. PubMed ID: 27009839
[TBL] [Abstract] [Full Text] [Related]
16. Genetic predisposition to neuroblastoma mediated by a lmo1 super-enhancer polymorphism.
Oldridge DA; Wood AC; Weichert-Leahey N; Crimmins I; Sussman R; Winter C; McDaniel LD; Diamond M; Hart LS; Zhu S; Durbin AD; Abraham BJ; Anders L; Tian L; Zhang S; Wei JS; Khan J; Bramlett K; Rahman N; Capasso M; Iolascon A; Gerhard DS; Guidry Auvil JM; Young RA; Hakonarson H; Diskin SJ; Look AT; Maris JM
Nature; 2015 Dec; 528(7582):418-21. PubMed ID: 26560027
[TBL] [Abstract] [Full Text] [Related]
17. Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of lmo1.
Lu J; Chu P; Wang H; Jin Y; Han S; Han W; Tai J; Guo Y; Ni X
PLoS One; 2015; 10(6):e0127856. PubMed ID: 26030754
[TBL] [Abstract] [Full Text] [Related]
18. Common genetic variants in NEFL influence gene expression and neuroblastoma risk.
Capasso M; Diskin S; Cimmino F; Acierno G; Totaro F; Petrosino G; Pezone L; Diamond M; McDaniel L; Hakonarson H; Iolascon A; Devoto M; Maris JM
Cancer Res; 2014 Dec; 74(23):6913-24. PubMed ID: 25312269
[TBL] [Abstract] [Full Text] [Related]
19. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.
Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A
Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812
[TBL] [Abstract] [Full Text] [Related]
20. Replication of neuroblastoma SNP association at the BARD1 locus in African-Americans.
Latorre V; Diskin SJ; Diamond MA; Zhang H; Hakonarson H; Maris JM; Devoto M
Cancer Epidemiol Biomarkers Prev; 2012 Apr; 21(4):658-63. PubMed ID: 22328350
[TBL] [Abstract] [Full Text] [Related]
[Next]
